Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis

Allergology International

Volumn 64, Issue 1, 2015, Pages 41-48

  Arima, Kazuhiko ^a   Ohta, Shoichiro ^a   Takagi, Atsushi ^b   Shiraishi, Hiroshi ^a   Masuoka, Miho ^a   Ontsuka, Kanako ^a   Suto, Hajime ^b   Suzuki, Shoichi ^a   Yamamoto, Ken ichi ^a   Ogawa, Masahiro ^a   Simmons, Olga ^c   Yamaguchi, Yukie ^d   Toda, Shuji ^a   Aihara, Michiko ^d   Conway, Simon J ^c   Ikeda, Shigaku ^b   Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermis; Hyperplasia; Imiquimod; Periostin; Psoriasis

Indexed keywords

IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; TRANSCRIPTION FACTOR RUNX2; AUTACOID; CELL ADHESION MOLECULE; CYTOKINE; POSTN PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; EMBRYO; EPIDERMIS HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MALE; MIDDLE AGED; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; SKIN SWELLING; ANIMAL; BIOPSY; DISEASE MODEL; EPIDERMIS; GENE EXPRESSION; GENETICS; HYPERPLASIA; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; SKIN;

ADULT; AGED; ANIMALS; BIOPSY; CELL ADHESION MOLECULES; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMANS; HYPERPLASIA; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LYMPHOCYTE SUBSETS; MALE; MICE; MIDDLE AGED; PSORIASIS; SKIN;

EID: 84942809186     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2014.06.001     Document Type: Article

References (28)

1. 1. Guttman-Yassky, E., Nograles, K.E., Krueger, J.G., Contrasting pathogenesis of atopic dermatitis and psoriasis–part I: clinical and pathologic concepts. J Allergy Clin Immunol 127 (2011), 1110–1118.
2. 2. Oyoshi, M.K., He, R., Kumar, L., Yoon, J., Geha, R.S., Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 102 (2009), 135–226.
3. 3. Lowes, M.A., Russell, C.B., Martin, D.A., Towne, J.E., Krueger, J.G., The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 34 (2013), 174–181.
4. 4. van der Fits, L., Mourits, S., Voerman, J.S., Kant, M., Boon, L., Laman, J., et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182 (2009), 5836–5845.
5. 5. Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35 (2011), 596–610.
6. 6. Van Belle, A.B., de Heusch, M., Lemaire, M.M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188 (2012), 462–469.
7. + innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122 (2012), 2252–2256.
8. 8. Gottlieb, A.B., Immunologic mechanisms in psoriasis. J Invest Dermatol 95 (1990), 18s–19s.
9. 9. Lindroos, J., Svensson, L., Norsgaard, H., Lovato, P., Moller, K., Hagedorn, P.H., et al. IL-23-mediated epidermal hyperplasia is dependent on IL-6. J Invest Dermatol 131 (2011), 1110–1118.
10. 10. Conway, S.J., Izuhara, K., Kudo, Y., Litvin, J., Markwald, R., Ouyang, et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 71 (2014), 1279–1288.
11. 11. Izuhara, K., Arima, K., Ohta, S., Suzuki, S., Inamitsu, M., Yamamoto, K., Periostin in allergic inflammation. Allergol Int 63 (2014), 143–151.
12. 12. Masuoka, M., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 122 (2012), 2590–2600.
13. 13. Shiraishi, H., Masuoka, M., Ohta, S., Suzuki, S., Arima, K., Taniguchi, K., et al. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes. Allergol Int 61 (2012), 563–572.
14. 14. Taniguchi, K., Arima, K., Masuoka, M., Ohta, S., Shiraishi, H., Ontsuka, K., et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 Loop. J Invest Dermatol 134 (2014), 1295–1304.
15. 15. Kou, K., Okawa, T., Yamaguchi, Y., Ono, J., Inoue, Y., Kohno, M., et al. Periostin levels correlate disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol 171 (2014), 283–291.
16. 16. Menter, A., Gottlieb, A., Feldman, S.R., Van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58 (2008), 826–850.
17. 17. Rios, H., Koushik, S.V., Wang, H., Wang, J., Zhou, H.M., Lindsley, et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 25 (2005), 11131–11144.
18. 18. Takayama, G., Arima, K., Kanaji, T., Toda, S., Tanaka, H., Shoji, S., et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118 (2006), 98–104.
19. 19. Tortola, L., Rosenwald, E., Abel, B., Blumberg, H., Schäfer, M., Coyle, A.J., et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 122 (2012), 3965–3976.
20. 20. Yuyama, N., Davies, D.E., Akaiwa, M., Matsui, K., Hamasaki, Y., Suminami, Y., et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19 (2002), 287–296.
21. 21. Ohta, N., Kurakami, K., Ishida, A., Furukawa, T., Saito, F., Kakehata, S., et al. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis. Laryngoscope 122 (2012), 572–577.
22. 22. Nishizawa, H., Matsubara, A., Nakagawa, T., Ohta, N., Izuhara, K., Shirasaki, T., et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol 132 (2012), 838–844.
23. 23. Ishida, A., Ohta, N., Suzuki, Y., Kakehata, S., Okubo, K., Ikeda, H., et al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 61 (2012), 589–595.
24. 24. Okamoto, M., Hoshino, T., Kitasato, Y., Sakazaki, Y., Kawayama, T., Fujimoto, K., et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 37 (2011), 1119–1127.
25. 25. Uchida, M., Shiraishi, H., Ohta, S., Arima, K., Taniguchi, K., Suzuki, S., et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 46 (2012), 677–686.
26. 26. Yamaguchi, Y., Ono, J., Masuoka, M., Ohta, S., Izuhara, K., Ikezawa, Z., et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol 168 (2013), 717–725.
27. 27. Yoshida, S., Ishikawa, K., Asato, R., Arima, M., Sassa, Y., Yoshida, A., et al. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 52 (2011), 5670–5678.
28. 28. Ishikawa, K., Yoshida, S., Nakao, S., Nakama, T., Kita, T., Asato, R., et al. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J 28 (2014), 131–142.